ACUR

Latest SEC Filings & News for ACUR

1 most recent filing and news item mentioning ACUR. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ACUR/news?limit=20"

Pull ACUR filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJun 29, 2026Neutral

Acura Pharmaceuticals amends loan schedule for promissory note

Acura Pharmaceuticals updated its loan schedule with Abuse Deterrent Pharma, LLC, increasing the total outstanding principal to approximately $10.7 million as of June 2026. This amendment details specific terms for additional loans ranging from 2022 to 2026.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.